R
René Adam
Researcher at Université Paris-Saclay
Publications - 634
Citations - 44864
René Adam is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 92, co-authored 578 publications receiving 37929 citations. Previous affiliations of René Adam include University of Padua & University of Paris.
Papers
More filters
Journal ArticleDOI
13 Liver transplantation of HIV-HCV and HIV-HBV coinfected patients: A large experience in a single centre
J.C. Duclos Vallee,Elina Teicher,Daniel Vittecoq,Cyrille Feray,A.M. Roque Afonso,Michelle Gigou,E. Dussaix,Catherine Guettier,Mylène Sebagh,Daniel Azoulay,René Adam,Philippe Ichai,Faouzi Saliba,Bruno Roche,D. Castaing,H. Bismuth,Didier Samuel +16 more
Journal ArticleDOI
Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond.
Thijmen Visseren,Nicole S. Erler,Wojciech G. Polak,René Adam,V. Karam,Florian W. R. Vondran,Bo-Göran Ericzon,Douglas Thorburn,Jan N. M. IJzermans,Andreas Paul,Frans van der Heide,Pavel Taimr,P. Nemec,Jacques Pirenne,Renato Romagnoli,Herold J. Metselaar,Sarwa Darwish Murad +16 more
TL;DR: In this article, the authors investigated the effect of post-transplant rPSC on graft and patient survival in a large European cohort, using Bayesian proportional hazards models to investigate the impact of re-recurrence of PSC and other covariates on patient and graft survival.
Journal ArticleDOI
Estrategias oncoquirúrgicas en el cáncer hepático metastásico
TL;DR: En esta revision, hemos descrito las estrategias oncoquirurgicas actuales empleadas en pacientes con MHCR en los that la reseccion esta indicada o no, sus beneficios y las estRategias of tratamiento futuro.
Journal ArticleDOI
Quality of life 10 years after liver transplantation: The impact of graft histology.
Vincent Karam,Mylène Sebagh,Kinan Rifai,Funda Yilmaz,Prashant Bhangui,Colette Danet,Faouzi Saliba,Didier Samuel,Denis Castaing,René Adam,Cyrille Feray +10 more
TL;DR: Long-term liver graft lesions, mainly HS presumably as a surrogate marker of HCV infection, may have a substantial impact on QOL 10 years after LT, according to a cohort of patients.